Detail information
| ID |
ENCL000138
|
|||||||||||||||||||
| Year | 2002 | |||||||||||||||||||
| Surgery | Hysterectomy | |||||||||||||||||||
| Acupoint |
|
|||||||||||||||||||
| Experimental Description | One hundred healthy consenting women undergoing lower abdominal surgery were randomly assigned to four treatment regimens: Group I (n =25), control; Group II (n=25), sham-EA (needle insertion without electrical stimulation); Group III (n =25), low-EA (2 Hz of electrical stimulation); and Group IV (n =25), high-EA (100 Hz of electrical stimulation). EA groups received needle insertion with or without electrical stimulation 20 min prior to anesthesia. All patients received patient-controlled analgesia (PCA) of morphine postoperation. | |||||||||||||||||||
| Sample Count | 100 | |||||||||||||||||||
| Age | >18 | |||||||||||||||||||
| Control |
Sham Freq Blank control(n=25); sham-EA(n=25)
|
|||||||||||||||||||
| Experiment | low-EA(n=25); high-EA(n=25) | |||||||||||||||||||
| Indicator | Visual analog scale(VAS) Number of PCA demands Time of the first required analgesic Total amount of morphine required by PCA Heart rate(HR) Blood pressure(BP) SpO2 Opioid-related adverse effects Nausea Vomiting Dizziness Pruritus | |||||||||||||||||||
| Auxiliary Medication | After removal of the needles, anesthesia was induced with i.v. thiopental 5 mg/kg and succinylcholine 2 mg/kg for tracheal intubation. Isoflurane in nitrous oxide 60% with oxygen 40% and an intermittent dose of atracurium were used for anesthesia maintenance without the use of opioids. Following surgery, all patients were transported to the recovery room. The time interval of the patient’s first request for pain medication was recorded (either pethidine 1 mg/kg i.m. during the first hour, which was restricted to a single dose, or as recorded by PCA when no request was made during the first hour). At 1 h postoperation, the PCA system was connected to the patient. The PCA device was programmed to intravenously deliver 2 mg morphine as ‘on demand’ doses with a minimum lockout interval of 10 min during the following 23 h. | |||||||||||||||||||
| Stimulation Method | EA | |||||||||||||||||||
| Induction Method |
|
|||||||||||||||||||
| Anesthesia Method |
AAA |
|||||||||||||||||||
| Clinical Trial Type | randomly | |||||||||||||||||||
| Contraindications | Patients with a history of opioid abuse, or significant cardiovascular, pulmonary, renal, hepatic or neurological disease were excluded | |||||||||||||||||||
| Effector |
We found that the time of first analgesic requested was 10, 18, 28, and 28 min in the control, sham-, low-, and high-EA groups, respectively. During the first 24 h, the total amount of morphine required was decreased by 21, 43 and 61% in the sham-, low- and high-EA groups, respectively. The incidence of nausea and dizziness during the first 24 h after surgery was significantly reduced in both the low-EA and high-EA groups compared with the control and sham-EA groups. We also found that sham-EA exerts a beneficial effect with respect to its pain relieving quality but not the side effect profiles. Our findings demonstrates that preoperative treatment with low-EA and high-EA can reduce postoperative analgesic requirements and associated side effects in patients undergoing lower abdominal surgery. Positive
|
|||||||||||||||||||
| Literature |
|
|||||||||||||||||||
